Klogene Therapeutics, Inc. Company
Klogene is developing therapeutics for prevention and treatment of age related diseases based on increasing the level of the naturally occurring Klotho protein in the human body
Founded Date:
2015-01-01
Last Funding Type:
Pre-Seed
Headquarters:
Boston, Massachusetts, United States
Investors Number:
8
Technology:
Immunotherapy
Employee Number:
11-50
Industry:
BioTech
Estimated Revenue:
$1M to $10M
Funding Status:
Seed
Investor Type:
For Profit
Total Funding:
1800000